Combination therapy with belimumab and low‐dose interleukin‐2 in a patient with anti‐MDA5 antibody dermatomyositis overlapping with systemic lupus erythematosus. - Feng, Ruiling; Zhang, Xia; He, Jing (Rheumatology & Autoimmunity, 2025)